Author | Patrick Ott, MD, PhD | OncLive

Author | Patrick Ott, MD, PhD

Articles

Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma

January 02, 2018

Video

Patrick Ott, MD, PhD, clinical director, Melanoma Center, Center for Immuno-Oncology, physician, assistant professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses ipilimumab (Yervoy) and nivolumab (Opdivo) both in combination and as a monotherapy for patients with melanoma.

Dr. Ott on the CheckMate-032 Study in Gastric and GEJ Cancer

July 06, 2017

Video

Patrick Ott, MD, PhD, clinical director, Melanoma Center, Center for Immuno-Oncology, physician, assistant professor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses the CheckMate-032 study in gastric and gastroesophageal junction cancer.

x